Abstract: The present invention provides anti-IL-6R monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of rheumatoid arthritis and other diseases.
Type:
Application
Filed:
February 28, 2012
Publication date:
September 6, 2012
Applicant:
APEXIGEN, INC.
Inventors:
Sum Wai Pierre Lee, Yaohuang Ke, Yongke Zhang